Skip to content


Rapid, Innovative Diagnostic Tests for Blood Disorders

Hematology Point of Care Tests

BioMedomics is proud of its innovative solutions for the diagnosis of important blood diseases. We’re dedicated to developing advanced point-of-care products which help deliver better health outcomes for patients. We give special attention to underserved patient populations and diseases where current diagnostic methods are quite costly and impractical for many communities around the world.

Sickle SCAN ®

BioMedomics Sickle SCAN, the world’s first rapid, point-of-care test for sickle cell disease and trait, makes diagnosis a reality for those who need it most. The test delivers lab-quality results in less than 5 minutes, eliminating the need for external equipment, power source, or trained lab technicians. Using just a drop of whole blood, clinicians can conduct the simple test in three easy steps. Sickle SCAN can be used anywhere, anytime giving physicians timely information vital for treatment decisions and reducing disparities in care for people located in remote and under-resourced communities.

Research & Development

BioMedomics patented lateral flow immunoassay technology duplicates the sensitivity and accuracy previously found only in central lab equipment. We’re pursuing additional hematology tests to add to this advanced point-of-care diagnostics platform. Products and technologies currently in development include both qualitative and quantitative point-of-care tests for significant hemoglobinopathies using standard and time-resolved lateral flow techniques.

We Help Diagnose

Sickle Cell Disease

Sickle cell disease (SCD) is a group of inherited blood disorders which affect hemoglobin, a protein that helps red blood cells carry oxygen throughout the body. Healthy red blood cells with normal hemoglobin are round and move easily through small blood vessels. Red blood cells with the abnormal hemoglobin S variant become sticky and sickle-shaped. These sickle cells tend to live only about 16 days compared to 120 days for normal red blood cells, causing a constant shortage of red blood cells (known as anemia). Also, the more rigid sickle-shaped blood may have difficulty passing through small blood vessels and block normal blood flow. Blockages cause pain and damage tissue, and ultimately lead to many of the complications of sickle cell disease.